Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo. Here, KLK7 is linked to obesity due to melanocortin 4 receptor deficiency.